Related Experiment Video
Updated: May 13, 2025

08:26
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
11.9K
Singlicate bead-based immunoassay for biomarker quantitation in sub-microliter volume sample.
Sang Hyun Lee1, Myeongsik Shin1, Chang Heon Lee1
1Department of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.
Biosensors & Bioelectronics
|May 11, 2025
Summary
A new Forward scattering Correction Using a Single-bead (FoCUS) method enables sensitive biomarker detection from minimal sample volumes. This innovation significantly improves detection limits for point-of-care testing devices.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Diagnostics
Background:
- Point-of-care testing (PoCT) is crucial for disease diagnostics.
- Detecting biomarkers from minimal sample volumes is challenging for PoCT.
Purpose of the Study:
- To develop a user-friendly method for biomarker detection using minimal sample volumes.
- To enhance sensitivity and reduce sample volume requirements for PoCT.
Main Methods:
- Introduced Forward scattering Correction Using a Single-bead (FoCUS) platform.
- Utilized tiny beads and a small chip for sample analysis.
- Employed a novel signal correction strategy using simultaneous forward scattering signals.
Main Results:
- Achieved a 1000-fold reduction in required sample volume.
- Decreased relative standard deviation of sample signals by 2.7-fold.
- Improved detection limits by 4.3-fold.
- Successfully detected myoglobin from 0.1 μL of sample.
Conclusions:
- FoCUS significantly reduces sample volume requirements for biomarker detection.
- The platform demonstrates high sensitivity and improved detection limits for PoCT.
- FoCUS shows potential for multiplex biomarker immunoassays in resource-limited settings.
Keywords:
Bead-based immunoassayForward scattering correctionMicrofluidicsSinglicateSubmicroliter analysis
